Table 2 Behavioral characteristics of study participants.

From: Prognostic plasma exosomal microRNA biomarkers in patients with substance use disorders presenting comorbid with anxiety and depression

 

HCs (M ± SD, n = 10)

HDPs (M ± SD, n = 10)

Adjusted p value (HC vs MDPs)

MDPs (M ± SD, n = 10)

Adjusted p value (HC vs MDPs)

VAS craving scale score

0

2.7 ± 1.95

5.5e–03

3.0 ± 2.36

2.1e−03

HAM-A

4.9 ± 2.42

15.3 ± 5.76

 < 1.0e−04

13.6 ± 3.86

3.0e−04

HAM-D

8.2 ± 3.82

15.2 ± 5.33

8.8e−03

11.7 ± 5.23

0.26

  1. M mean, SD standard deviation, VAS Visual-Analogue Craving Scale, MDPs methamphetamine-dependent patients, HDPs heroin-dependent patients, HCs healthy controls.